Cumberland Pharmaceuticals Inc. (CPIX)

Business: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally.

IPO Date: 11-Aug-2009

Founder, Chairman, Pres & CEO: Mr. A. J. Kazimi MBA

Sr. Director of Fin. & Accounting and CFO: Mr. John Michael Hamm

Listing: NASDAQ: CPIX

Country: United States

Headquarters: Nashville, TN

Website: https://www.cumberlandpharma.com

Market cap: $30.12 Mln

Revenue (TTM): $36.62 Mln

Earnings (TTM): $-5.06 Mln

Cash: $17.27 Mln

Total Debt: $20.79 Mln

Insider's Holding: 44.41%

Liquidity: Low

52 Week range: $1.89 - 7.51

Shares outstanding: 14,766,500

10 Years Aggregate:

• CFO: $36.40 Mln
• EBITDA: $13.74 Mln
• Net Profit: $-19.47 Mln